➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Mallinckrodt
Harvard Business School
Moodys
McKinsey

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,789,064


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,789,064
Title:Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide
Abstract: Micro-capsules for the slow release of drugs, consisting of a lactic-co-glycolic copolymer to which a plasticizer has been incorporated and which contain a drug of pharmaceutical interested within them.
Inventor(s): Parente Duena; Antonio (Barcelona, ES), Garces Garces; Josep (Barcelona, ES), Bonilla Munoz; Angel (Barcelona, ES), Cunillera Colome; David (Barcelona, ES)
Assignee: GP PHARM, S.A. (Barcelona, ES)
Application Number:12/148,893
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 9,789,064

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gp-pharm Sa LUTRATE DEPOT KIT leuprolide acetate FOR SUSPENSION;INTRAMUSCULAR 205054-001 Aug 28, 2018 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,789,064

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Spain9902768Dec 17, 1999

International Family Members for US Patent 9,789,064

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 234608   Start Trial
Australia 2173501   Start Trial
Australia 774680   Start Trial
Brazil 0008197   Start Trial
Brazil PI0008197   Start Trial
Canada 2362769   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
AstraZeneca
Colorcon
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.